Moleculin Biotech, Inc. generated $0 in revenue in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to $0 in revenue. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Moleculin Biotech, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
MBRX Revenue by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
MBRX Revenue by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Moleculin Biotech, Inc. financials
Frequently Asked Questions
Moleculin Biotech, Inc. generated $0 in revenue in fiscal year 2025.
Moleculin Biotech, Inc. (MBRX) reported $0 in revenue in fiscal year 2024 and $0 in revenue in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Moleculin Biotech, Inc. (MBRX) reported $0 in revenue over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
Moleculin Biotech, Inc. (MBRX) reported $0 in revenue in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Moleculin Biotech, Inc. (MBRX) reported on that line in every period on record.